Literature DB >> 24980193

Prostate cancer: intriguing data on inflammation and prostate cancer.

Linda Vignozzi1, Mario Maggi1.   

Abstract

A new case–control study shows that inflammation on biopsy is associated with diagnosis of prostate cancer. We think a large population-based prospective study, specifically designed to investigate the longitudinal association between inflammation and subsequent onset of prostate cancer, is required to elucidate the true relationship between inflammation and prostate carcinogenesis.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24980193     DOI： 10.1038/nrurol.2014.143

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


  10 in total

1.  Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer.

Authors:  Sabina Davidsson; Michelangelo Fiorentino; Ove Andrén; Fang Fang; Lorelei A Mucci; Eberhard Varenhorst; Katja Fall; Jennifer R Rider
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-27       Impact factor: 4.254

Review 2.  Benign prostatic hyperplasia: a new metabolic disease?

Authors:  L Vignozzi; G Rastrelli; G Corona; M Gacci; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2014-01-24       Impact factor: 4.256

3.  False alarms and pseudo-epidemics: the limitations of observational epidemiology.

Authors:  David A Grimes; Kenneth F Schulz
Journal:  Obstet Gynecol       Date:  2012-10       Impact factor: 7.661

4.  Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.

Authors:  Tytti H Yli-Hemminki; Marita Laurila; Anssi Auvinen; Liisa Määttänen; Heini Huhtala; Teuvo L J Tammela; Paula M Kujala
Journal:  BJU Int       Date:  2013-06-07       Impact factor: 5.588

Review 5.  Inflammation in prostate carcinogenesis.

Authors:  Angelo M De Marzo; Elizabeth A Platz; Siobhan Sutcliffe; Jianfeng Xu; Henrik Grönberg; Charles G Drake; Yasutomo Nakai; William B Isaacs; William G Nelson
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

6.  High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Pathologist Multi Center Study Group.

Authors:  J Irani; J M Goujon; E Ragni; L Peyrat; J Hubert; F Saint; N Mottet
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

Review 7.  Human prostate cancer risk factors.

Authors:  David G Bostwick; Harry B Burke; Daniel Djakiew; Susan Euling; Shuk-mei Ho; Joseph Landolph; Howard Morrison; Babasaheb Sonawane; Tiffany Shifflett; David J Waters; Barry Timms
Journal:  Cancer       Date:  2004-11-15       Impact factor: 6.860

8.  Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study.

Authors:  Daniel M Moreira; J Curtis Nickel; Leah Gerber; Roberto L Muller; Gerald L Andriole; Ramiro Castro-Santamaria; Stephen J Freedland
Journal:  Cancer       Date:  2013-12-09       Impact factor: 6.860

9.  Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Authors:  Bora Gurel; M Scott Lucia; Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; Alan R Kristal; Howard L Parnes; Ashraful Hoque; Scott M Lippman; Siobhan Sutcliffe; Sarah B Peskoe; Charles G Drake; William G Nelson; Angelo M De Marzo; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-18       Impact factor: 4.254

Review 10.  Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.

Authors:  Giovanni Corona; Linda Vignozzi; Giulia Rastrelli; Francesco Lotti; Sarah Cipriani; Mario Maggi
Journal:  Int J Endocrinol       Date:  2014-02-13       Impact factor: 3.257
  10 in total
  13 in total

1.  5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia.

Authors:  C-H Chou; C-L Lin; M-C Lin; F-C Sung; C-H Kao
Journal:  J Endocrinol Invest       Date:  2015-03-17       Impact factor: 4.256

Review 2.  Inflammation and prostate cancer: friends or foe?

Authors:  Gianluigi Taverna; Elisa Pedretti; Giuseppe Di Caro; Elena Monica Borroni; Federica Marchesi; Fabio Grizzi
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

3.  Prostate calculi can higher urinary retention probability and worsen uncomfortable feeling after prostate biopsy but not predict cancer.

Authors:  Meng Gu; Wenzhi Li; Qi Chen; Yanbo Chen; Mingxi Xu; Zhong Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?

Authors:  Bu Hyeon Yun; Eu Chang Hwang; Ho Song Yu; Hoseok Chung; Sun-Ouck Kim; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Chan Choi
Journal:  Int Urol Nephrol       Date:  2015-06-14       Impact factor: 2.370

5.  Prostate hyperplasia caused by long-term obesity is characterized by high deposition of extracellular matrix and increased content of MMP-9 and VEGF.

Authors:  Silas Amâncio Silva; Marina Guimarães Gobbo; Maria Etelvina Pinto-Fochi; Alex Rafacho; Sebastião Roberto Taboga; Eduardo Alves Almeida; Rejane Maira Góes; Daniele Lisboa Ribeiro
Journal:  Int J Exp Pathol       Date:  2014-12-21       Impact factor: 1.925

Review 6.  Meta-analysis of metabolic syndrome and prostate cancer.

Authors:  M Gacci; G I Russo; C De Nunzio; A Sebastianelli; M Salvi; L Vignozzi; A Tubaro; G Morgia; S Serni
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-02-21       Impact factor: 5.554

7.  Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality.

Authors:  Crystal S Langlais; Rebecca E Graff; Erin L Van Blarigan; Stacey A Kenfield; John Neuhaus; Fred K Tabung; Janet E Cowan; Jeanette M Broering; Peter Carroll; June M Chan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-09-02       Impact factor: 4.090

Review 8.  Inflammatory mediators in the development and progression of benign prostatic hyperplasia.

Authors:  Cosimo De Nunzio; Fabrizio Presicce; Andrea Tubaro
Journal:  Nat Rev Urol       Date:  2016-09-30       Impact factor: 14.432

9.  Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer.

Authors:  Yun Luo; Qi-Wei Jiang; Jie-Ying Wu; Jian-Ge Qiu; Wen-Ji Zhang; Xiao-Long Mei; Zhi Shi; Jin-Ming Di
Journal:  Oncotarget       Date:  2015-09-08

10.  Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.

Authors:  Hao Peng; Xiaogang Luo
Journal:  Cancer Cell Int       Date:  2019-03-25       Impact factor: 5.722
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.